Basic information |
Metabolite name | Xanthosine |
HMDB0000299 | |
C01762 | |
64959 | |
Synonyms | NA |
No. of studies | 15 |
Relationship between Xanthosine and depression (count: 15) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M024 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
Study M024 | Type2 | CUMS + high dose of Xiaoyaosan group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
Study M1032 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
Study M1090 | Type1 | CUMS group vs. control group | Plasma | BALb/c mouse | Down |
Study M1090 | Type2 | CUMS + hyperbaric oxygen treatment group vs. CUMS group | Plasma | BALb/c mouse | Up |
Study M1099 | Type2 | chronic social isolation + fluoxetine group vs. chronic social isolation group | Prefrontal cortex | Wistar rat | Down |
Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
Study M602 | Type1 | MDD group vs. control group | Plasma | Human | Down |
Study M613 | Type1 | CSDS susceptible group vs. control group | Ventral hippocampus | C57BL/6 J mouse | Down |
Study M632 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Unknown |
Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Thyroid | ICR mouse | Down |
Study M814 | Type1 | CSDS group vs. control group | Serum | C57BL/6J mouse | Down |
Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Up |
Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Down |
Study M957 | Type1 | CSDS group vs. control group | Serum | C57BL/6 J mouse | Up |
Study M957 | Type1 | CSDS group vs. control group | Hippocampus | C57BL/6 J mouse | Up |